Catalog No.S2467 Synonyms: BRL-42810

For research use only.

Famciclovir (BRL-42810) is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections.

Famciclovir  Chemical Structure

CAS No. 104227-87-4

Selleck's Famciclovir has been cited by 9 Publications

Purity & Quality Control

Choose Selective Antiviral Inhibitors

Biological Activity

Description Famciclovir (BRL-42810) is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections.

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 321.33863


CAS No. 104227-87-4
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05283551 Recruiting Drug: Famciclovir Multiple Sclerosis Queen Mary University of London November 25 2020 Phase 2
NCT00878072 Completed Drug: Famciclovir Herpes Labialis Novartis Pharmaceuticals|Novartis March 25 2009 Phase 2|Phase 3
NCT01154543 Completed -- HIV Positive|Herpes Simplex Genital Holdsworth House Medical Practice March 2008 --
NCT00448227 Completed Drug: famciclovir Herpes Simplex Novartis October 2007 Phase 2
NCT00098059 Completed Drug: Famciclovir Herpes Simplex Novartis Pharmaceuticals|Novartis February 2005 Phase 3

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Famciclovir | Famciclovir ic50 | Famciclovir price | Famciclovir cost | Famciclovir solubility dmso | Famciclovir purchase | Famciclovir manufacturer | Famciclovir research buy | Famciclovir order | Famciclovir mouse | Famciclovir chemical structure | Famciclovir mw | Famciclovir molecular weight | Famciclovir datasheet | Famciclovir supplier | Famciclovir in vitro | Famciclovir cell line | Famciclovir concentration | Famciclovir nmr